Epidemiological And Clinical Profile, And Survival Of Patients Followed For Breast Cancer Between 2010 And 2015 At The Yaounde General Hospital, Cameroon

Introduction: approximately 6000 Cameroonian women died of cancer in 2018, and the breast is the most affected with 2625 new cases. The aim of this study was to establish a pattern of malignant breast tumours in Yaounde (Cameroon). Methods: this study was a descriptive and analytical retrospective study of breast cancer between January 2010 and December 2015 in Yaounde General Hospital (YGH) after the Institutional ethics committee approval. The variables studied were the socio-demographic characteristics, risk factors for breast cancer, types of tumours and type of treatments. The 5-year survival was analyzed by the Kaplan-Meier method. The adjusted hazard ratios and their 95% confidence intervals were calculated to assess the association between studied variables and patient survival through the cox regression using SPSS 23 software. The difference was considered significant at p < 0.05. Results: among the 344 files collected in this study, breast cancer patients were predominantly female (96.64%, n = 288) aged 45.39 +/- 13.35 years, with invasive ductal carcinoma (68.03%, n = 270), located in the left breast (52%, n= 147). The average tumour size was similar to 6.5 +/- 0.3 cm and diagnosed in grade II of Scarf Bloom Richardson (SBR) in 60% (n= 150) of cases. The 5-year survival was 43.3%. Factors associated with this poor survival were the religion (alpha HR 5.05, 95% CI: 1.57 - 16.25; p = 0.007 for animist and alpha HR 4.2, 95% CI: 1.53 - 11.46; p = 0.005 for protestant), location of the tumour (alpha HR 6.24, 95% CI: 1.58 - 24.60; p = 0.012), tumor height (alpha HR 0.21, 95% CI: 0.04 - 1.11; p = 0.011) and the time spent before medical treatment (alpha HR 5.12, 95% CI: 0.39 - 8.38; p = 0.011). Conclusion: the young age, large tumour size and high histological grade in our studied population suggest a weak awareness of women about breast cancer. Action should be taken in early screening to improve the management of breast cancer in Cameroon.